Original Source(s)
Related Content
FDA Expands Guselkumab Label in PsA
Phase 3b APEX findings support the addition of structural joint damage inhibition data to the prescribing information.
May 29, 2026
-
2 min
Parallel Ridge Pattern Signals Acral Melanoma Risk
Meta-analysis supports multi-feature dermoscopic evaluation.
April 28, 2026
-
3 min
EULAR Updates Behçet’s Syndrome Recommendations
EULAR releases updated recommendations supporting earlier biologic use in patients with eye, vascular, and nervous system involvement
April 1, 2026
-
5 min
